Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05415748 · ClinicalTrials.gov registry record · Phase 4
Deprescribing Tamsulosin in Older Men
A Phase 4 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 31
- Enrollment target
NCT05415748 is a Phase 4 study that has completed, run by University of California, San Francisco. The registered enrollment target is 31 participants.
The verdict
NCT05415748, a Phase 4 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 31 participants
- Enrollment target
Study Summary
This is a pilot 12-week randomized, placebo-controlled N-of-1 deprescribing trial among older men receiving chronic tamsulosin therapy for lower urinary tract symptoms attributed to benign prostatic hyperplasia.
Interventions
- DRUG Placebo
- DRUG Tamsulosin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2021-09-18 |
| Est. Completion | 2022-07-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05415748
The ClinicalTrials.gov registry entry for NCT05415748 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05415748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05415748 about?
NCT05415748 is a clinical study titled "Deprescribing Tamsulosin in Older Men". This is a pilot 12-week randomized, placebo-controlled N-of-1 deprescribing trial among older men receiving chronic tamsulosin therapy for lower urinary tract symptoms attributed to benign prostatic hyperplasia.
What is the current status of trial NCT05415748?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 31 participants. The study started on 2021-09-18. Estimated completion is 2022-07-22.
What interventions are being tested in trial NCT05415748?
The interventions under investigation include: Placebo (DRUG), Tamsulosin (DRUG).
Who is sponsoring clinical trial NCT05415748?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.